MEDIPAL HOLDINGS (Germany) Performance
| 59Z Stock | EUR 14.40 0.10 0.70% |
The company secures a Beta (Market Risk) of 0.43, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MEDIPAL HOLDINGS's returns are expected to increase less than the market. However, during the bear market, the loss of holding MEDIPAL HOLDINGS is expected to be smaller as well. At this point, MEDIPAL HOLDINGS P has a negative expected return of -0.12%. Please make sure to verify MEDIPAL HOLDINGS's coefficient of variation, variance, and the relationship between the mean deviation and standard deviation , to decide if MEDIPAL HOLDINGS P performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days MEDIPAL HOLDINGS P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
MEDIPAL |
MEDIPAL HOLDINGS Relative Risk vs. Return Landscape
If you would invest 1,570 in MEDIPAL HOLDINGS P on September 24, 2024 and sell it today you would lose (130.00) from holding MEDIPAL HOLDINGS P or give up 8.28% of portfolio value over 90 days. MEDIPAL HOLDINGS P is currently producing negative expected returns and takes up 1.3624% volatility of returns over 90 trading days. Put another way, 12% of traded stocks are less volatile than MEDIPAL, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
MEDIPAL HOLDINGS Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MEDIPAL HOLDINGS's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MEDIPAL HOLDINGS P, and traders can use it to determine the average amount a MEDIPAL HOLDINGS's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0909
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 59Z |
Estimated Market Risk
| 1.36 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MEDIPAL HOLDINGS is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MEDIPAL HOLDINGS by adding MEDIPAL HOLDINGS to a well-diversified portfolio.
MEDIPAL HOLDINGS Fundamentals Growth
MEDIPAL Stock prices reflect investors' perceptions of the future prospects and financial health of MEDIPAL HOLDINGS, and MEDIPAL HOLDINGS fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MEDIPAL Stock performance.
| Return On Equity | 0.0597 | |||
| Return On Asset | 0.0161 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.01 % | |||
| Shares Outstanding | 209.96 M | |||
| Price To Earning | 17.52 X | |||
| Revenue | 3.35 T | |||
| EBITDA | 60.12 B | |||
| Cash And Equivalents | 230.57 B | |||
| Total Debt | 30.36 B | |||
| Debt To Equity | 0.05 % | |||
| Book Value Per Share | 2,636 X | |||
| Cash Flow From Operations | 34.45 B | |||
| Earnings Per Share | 0.89 X | |||
About MEDIPAL HOLDINGS Performance
By analyzing MEDIPAL HOLDINGS's fundamental ratios, stakeholders can gain valuable insights into MEDIPAL HOLDINGS's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MEDIPAL HOLDINGS has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MEDIPAL HOLDINGS has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business. The company was founded in 1898 and is headquartered in Tokyo, Japan. MEDIPAL HOLDINGS operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12971 people.Things to note about MEDIPAL HOLDINGS P performance evaluation
Checking the ongoing alerts about MEDIPAL HOLDINGS for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MEDIPAL HOLDINGS P help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MEDIPAL HOLDINGS P generated a negative expected return over the last 90 days |
- Analyzing MEDIPAL HOLDINGS's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MEDIPAL HOLDINGS's stock is overvalued or undervalued compared to its peers.
- Examining MEDIPAL HOLDINGS's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MEDIPAL HOLDINGS's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MEDIPAL HOLDINGS's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MEDIPAL HOLDINGS's stock. These opinions can provide insight into MEDIPAL HOLDINGS's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MEDIPAL Stock analysis
When running MEDIPAL HOLDINGS's price analysis, check to measure MEDIPAL HOLDINGS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIPAL HOLDINGS is operating at the current time. Most of MEDIPAL HOLDINGS's value examination focuses on studying past and present price action to predict the probability of MEDIPAL HOLDINGS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIPAL HOLDINGS's price. Additionally, you may evaluate how the addition of MEDIPAL HOLDINGS to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |